Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Childhood asthma in the new omics era: challenges and perspectives.

Current opinion in allergy and clinical immunology - 1 Apr 2020

Golebski Korneliusz, Kabesch Michael, Melén Erik, Potočnik Uroš, van Drunen Cornelis M, Reinarts Susanne, Maitland-van der Zee Anke H, Vijverberg Susanne J H

Abstract excerpt

PURPOSE OF REVIEW: Childhood asthma is a heterogeneous inflammatory disease comprising different phenotypes and endotypes and, particularly in its severe forms, has a large impact on the quality-of-life of patients and caregivers. The application of advanced omics technologies provides useful insights into underlying asthma endotypes and may provide potential clinical biomarkers to guide treatment and move...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Asthmatic Agents
Share to Asthma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biological Products

Share to Epigenomics

Share to Metabolomics

Share to Pharmacogenomic Testing

Share to Precision Medicine

Share to Proteomics

Source

Open in PubMed Open full text

Identifiers

PMID: 31985545
DOI: 10.1097/ACI.0000000000000626
PMCID: PMC7060050

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Childhood asthma in the new omics era: challenges and perspectives.PMID 31985545Read ↗

Multi-Omics Profiling Approach to Asthma: An Evolving ParadigmSemantic proximity Read ↗

Recent advances in the treatment of childhood asthma: a clinical pharmacology perspective.Semantic proximity Read ↗

The use of pharmacogenomics, epigenomics, and transcriptomics to improve childhood asthma management: Where do we stand?Semantic proximity Read ↗

Omics approaches in asthma research: Challenges and opportunitiesSemantic proximity Read ↗

Unraveling heterogeneity and treatment of asthma through integrating multi-omics dataSemantic proximity Read ↗

What did we learn from multiple omics studies in asthma?Semantic proximity Read ↗

Towards precision medicine: The application of omics technologies in asthma managementSemantic proximity Read ↗

Precision Medicine in Targeted Therapies for Severe Asthma: Is There Any Place for "Omics" Technology?Semantic proximity Read ↗

Linking childhood allergic asthma phenotypes with endotype through integrated systems biology: current evidence and research needs.Semantic proximity Read ↗

Childhood asthma: pathogenesis and phenotypes.Semantic proximity Read ↗

The evolution of scientific knowledge in childhood asthma over time.Semantic proximity Read ↗

Current understanding and future directions in severe asthma through artificial intelligence-integrated multi-omic approaches.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.